Fulgent Genetics, Inc. (FLGT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
FLGT Revenue Growth
Revenue Breakdown (FY 2025)
FLGT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
FLGT Revenue Analysis (2014–2025)
As of May 7, 2026, Fulgent Genetics, Inc. (FLGT) generated trailing twelve-month (TTM) revenue of $322.7 million, reflecting solid growth of +9.3% year-over-year. The most recent quarter (Q4 2025) recorded $83.3 million in revenue, down 0.9% sequentially.
Looking at the longer-term picture, FLGT's 5-year compound annual growth rate (CAGR) stands at -5.2%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $992.6 million in 2021.
Revenue diversification analysis shows FLGT's business is primarily driven by Laboratory Services (100%). With over half of revenue concentrated in Laboratory Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NTRA (+38.2% YoY), EXAS (+17.7% YoY), and PACB (-10.7% YoY), FLGT has underperformed the peer group in terms of revenue growth. Compare FLGT vs NTRA →
FLGT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| FLGTCurrent | $323M | +9.3% | -5.2% | -28.2% | |
 NTRA | $1.7B | +38.2% | +41.2% | -13.1% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 PACB | $154M | -10.7% | +11.1% | -308.0% | |
 LH | $14.0B | +7.3% | -0.0% | 10.9% | |
 DGX | $11.0B | +11.0% | +3.2% | 14.5% |
FLGT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $322.7M | +13.8% | $130.9M | 40.6% | $-91,096,000 | -28.2% |
| 2024 | $283.5M | -2.0% | $107.2M | 37.8% | $-73,918,000 | -26.1% |
| 2023 | $289.2M | -53.3% | $104.5M | 36.1% | $-195,529,000 | -67.6% |
| 2022 | $619.0M | -37.6% | $366.9M | 59.3% | $178.5M | 28.8% |
| 2021 | $992.6M | +135.4% | $777.1M | 78.3% | $676.0M | 68.1% |
| 2020 | $421.7M | +1196.5% | $331.9M | 78.7% | $290.2M | 68.8% |
| 2019 | $32.5M | +52.3% | $18.4M | 56.6% | $-428,000 | -1.3% |
| 2018 | $21.4M | +14.0% | $10.7M | 49.9% | $-5,070,000 | -23.7% |
| 2017 | $18.7M | +2.5% | $10.2M | 54.3% | $-3,482,000 | -18.6% |
| 2016 | $18.3M | +90.9% | $11.6M | 63.2% | $919K | 5.0% |
See FLGT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FLGT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FLGT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFLGT — Frequently Asked Questions
Quick answers to the most common questions about buying FLGT stock.
Is FLGT's revenue growth accelerating or slowing?
FLGT maintains +9.3% revenue growth, in line with its 5-year CAGR of -5.2%. TTM revenue stands at $323M. Growth rate remains consistent with historical average.
What is FLGT's long-term revenue growth rate?
Fulgent Genetics, Inc.'s 5-year revenue CAGR of -5.2% reflects the sustained expansion pattern. Current YoY growth of +9.3% is near this long-term average.
How is FLGT's revenue distributed by segment?
FLGT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.